LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 95

Search options

  1. Article ; Online: Naru-3 inhibits inflammation, synovial hyperplasia, and neovascularization in collagen-induced arthritis in rats.

    Zhao, Haiyue / Duan, Shasha / Shi, Yilu / Zhang, Minjie / Zhang, Lu / Jin, Zhiyuan / Fu, Wenyan / Xiao, Wuping / Bai, Tianhao / Zhang, Xiaoshan / Wang, Yaxi

    Journal of ethnopharmacology

    2023  Volume 311, Page(s) 116350

    Abstract: Ethnopharmacological relevance: Naru-3 is a prescribed formulation based on the theory ... of Mongolian medicine for the treatment of rheumatoid arthritis (RA). Naru-3 consists of three medicinal agents ... rheumatism for centuries.: Background: Mongolian medicine Naru-3 is commonly prescribed to treat RA ...

    Abstract Ethnopharmacological relevance: Naru-3 is a prescribed formulation based on the theory of Mongolian medicine for the treatment of rheumatoid arthritis (RA). Naru-3 consists of three medicinal agents: Aconitum kusnezoffii Reichb (caowu), Terminalia chebula Retz (hezi), and Piper longum L (biba). These medicinal agents are widely distributed in the Mongolian area of China and have been used to treat rheumatism for centuries.
    Background: Mongolian medicine Naru-3 is commonly prescribed to treat RA, but its mechanism of action is unknown.
    Methods: A rat collagen-induced arthritis (CIA) model was established to investigate the mechanism of Naru-3. Rats were treated with Naru-3, Etanercept (ETN), and sodium carboxymethylcellulose (CMC) for four weeks. After treatment was terminated, paw thickness, ankle diameter, and arthritis index (AI) were scored. Synovial hyperplasia was evaluated using hematoxylin and eosin (H&E) staining and two-dimensional ultrasonography. Synovitis and neovascularization were assayed using power Doppler imaging (PDI) and contrast-enhanced ultrasonography (CEUS). Levels of vascular endothelial growth factor (VEGF), interleukin (IL)-1, and CD31 in the serum or synovium were detected using ELISA and immunohistochemistry analyses.
    Results: Naru-3 and ETN alleviated the symptoms of CIA as evidenced by diminished paw thickness, ankle diameter, and AI scores. Mechanistically, Naru-3 inhibited synovial hyperplasia, synovitis, and neovascularization by diminishing systemic and local inflammation, as indicated by the relative expression of CD31, VEGF and IL-1 in the serumor synovium. After four weeks of treatment, no significant neovascularization was observed in the Naru-3 group, but neovascularization and synovitis occurred in the ETN group, as demonstrated by H&E staining, PDI, and CEUS examination.
    Conclusion: Naru-3 inhibited inflammation, synovial hyperplasia, and neovascularization and alleviates RA in our CIA rat model. No symptom recurrence was observed four weeks after drug treatment.
    MeSH term(s) Rats ; Animals ; Arthritis, Experimental/chemically induced ; Arthritis, Experimental/diagnostic imaging ; Arthritis, Experimental/drug therapy ; Vascular Endothelial Growth Factor A/metabolism ; Hyperplasia/pathology ; Synovial Membrane/metabolism ; Inflammation/pathology ; Arthritis, Rheumatoid/pathology ; Synovitis/metabolism ; Synovitis/pathology ; Neovascularization, Pathologic/drug therapy
    Chemical Substances Vascular Endothelial Growth Factor A
    Language English
    Publishing date 2023-04-03
    Publishing country Ireland
    Document type Journal Article
    ZDB-ID 134511-4
    ISSN 1872-7573 ; 0378-8741
    ISSN (online) 1872-7573
    ISSN 0378-8741
    DOI 10.1016/j.jep.2023.116350
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Naru-3 inhibits inflammation, synovial hyperplasia, and neovascularization in collagen-induced arthritis in rats

    Zhao, Haiyue / Duan, Shasha / Shi, Yilu / Zhang, Minjie / Zhang, Lu / Jin, Zhiyuan / Fu, Wenyan / Xiao, Wuping / Bai, Tianhao / Zhang, Xiaoshan / Wang, Yaxi

    Journal of Ethnopharmacology. 2023 July, v. 311 p.116350-

    2023  

    Abstract: Naru-3 is a prescribed formulation based on the theory of Mongolian medicine for the treatment ... of rheumatoid arthritis (RA). Naru-3 consists of three medicinal agents: Aconitum kusnezoffii Reichb (caowu ... in the Mongolian area of China and have been used to treat rheumatism for centuries. Mongolian medicine Naru-3 is ...

    Abstract Naru-3 is a prescribed formulation based on the theory of Mongolian medicine for the treatment of rheumatoid arthritis (RA). Naru-3 consists of three medicinal agents: Aconitum kusnezoffii Reichb (caowu), Terminalia chebula Retz (hezi), and Piper longum L (biba). These medicinal agents are widely distributed in the Mongolian area of China and have been used to treat rheumatism for centuries. Mongolian medicine Naru-3 is commonly prescribed to treat RA, but its mechanism of action is unknown. A rat collagen-induced arthritis (CIA) model was established to investigate the mechanism of Naru-3. Rats were treated with Naru-3, Etanercept (ETN), and sodium carboxymethylcellulose (CMC) for four weeks. After treatment was terminated, paw thickness, ankle diameter, and arthritis index (AI) were scored. Synovial hyperplasia was evaluated using hematoxylin and eosin (H&E) staining and two-dimensional ultrasonography. Synovitis and neovascularization were assayed using power Doppler imaging (PDI) and contrast-enhanced ultrasonography (CEUS). Levels of vascular endothelial growth factor (VEGF), interleukin (IL)-1, and CD31 in the serum or synovium were detected using ELISA and immunohistochemistry analyses. Naru-3 and ETN alleviated the symptoms of CIA as evidenced by diminished paw thickness, ankle diameter, and AI scores. Mechanistically, Naru-3 inhibited synovial hyperplasia, synovitis, and neovascularization by diminishing systemic and local inflammation, as indicated by the relative expression of CD31, VEGF and IL-1 in the serumor synovium. After four weeks of treatment, no significant neovascularization was observed in the Naru-3 group, but neovascularization and synovitis occurred in the ETN group, as demonstrated by H&E staining, PDI, and CEUS examination. Naru-3 inhibited inflammation, synovial hyperplasia, and neovascularization and alleviates RA in our CIA rat model. No symptom recurrence was observed four weeks after drug treatment.
    Keywords Aconitum kusnezoffii ; Piper longum ; Terminalia chebula ; angiogenesis ; animal models ; blood serum ; carboxymethylcellulose ; drug therapy ; eosin ; hyperplasia ; immunohistochemistry ; inflammation ; interleukin-1 ; mechanism of action ; rats ; rheumatoid arthritis ; synovitis ; traditional medicine ; ultrasonography ; vascular endothelial growth factors ; China ; Naru-3 ; Neovascularization ; Contrast-enhanced ultrasound ; Power Doppler imaging ; 2D ; AI ; AUC ; CEUS ; CIA ; CMC ; DMARDs ; ETN ; H&E ; IL-1β ; PDI ; PI ; RA ; S ; TIC ; TNF ; TTP ; VEGF
    Language English
    Dates of publication 2023-07
    Publishing place Elsevier B.V.
    Document type Article ; Online
    Note Use and reproduction
    ZDB-ID 134511-4
    ISSN 1872-7573 ; 0378-8741
    ISSN (online) 1872-7573
    ISSN 0378-8741
    DOI 10.1016/j.jep.2023.116350
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  3. Article ; Online: Corrigendum: Advancement in the development of therapeutics against Zika virus infection.

    Li, Kangchen / Ji, Qianting / Jiang, Shibo / Zhang, Naru

    Frontiers in cellular and infection microbiology

    2022  Volume 12, Page(s) 1006226

    Abstract: This corrects the article DOI: 10.3389/fcimb.2022.946957.]. ...

    Abstract [This corrects the article DOI: 10.3389/fcimb.2022.946957.].
    Language English
    Publishing date 2022-08-26
    Publishing country Switzerland
    Document type Published Erratum
    ZDB-ID 2619676-1
    ISSN 2235-2988 ; 2235-2988
    ISSN (online) 2235-2988
    ISSN 2235-2988
    DOI 10.3389/fcimb.2022.1006226
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Advancement in the Development of Therapeutics Against Zika Virus Infection.

    Li, Kangchen / Ji, Qianting / Jiang, Shibo / Zhang, Naru

    Frontiers in cellular and infection microbiology

    2022  Volume 12, Page(s) 946957

    Abstract: Zika virus (ZIKV), a re-emerging arbovirus, causes teratogenic effects on the fetus and normal nerve functions, resulting in harmful autoimmune responses, which call for the development of therapeutics against ZIKV infection. In this review, we introduce ...

    Abstract Zika virus (ZIKV), a re-emerging arbovirus, causes teratogenic effects on the fetus and normal nerve functions, resulting in harmful autoimmune responses, which call for the development of therapeutics against ZIKV infection. In this review, we introduce the pathogenesis of ZIKV infection and summarize the advancement in the development of therapeutics against ZIKV infection. It provides guidance for the development of effective therapeutics against ZIKV infection.
    MeSH term(s) Humans ; Viral Nonstructural Proteins ; Zika Virus ; Zika Virus Infection/therapy
    Chemical Substances Viral Nonstructural Proteins
    Language English
    Publishing date 2022-07-08
    Publishing country Switzerland
    Document type Journal Article ; Review ; Research Support, Non-U.S. Gov't
    ZDB-ID 2619676-1
    ISSN 2235-2988 ; 2235-2988
    ISSN (online) 2235-2988
    ISSN 2235-2988
    DOI 10.3389/fcimb.2022.946957
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: A subunit-based influenza/SARS-CoV-2 Omicron combined vaccine induced potent protective immunity in BALB/c mice.

    Zhang, Naru / Ye, Zihui / Li, Cun / Zhou, Jie / Xue, Wei / Xiang, Luying / Chen, Yuewen / Chen, Shuchang / Ye, Rouhan / Dong, Jingyin / Jiang, Shibo / Han, Haijun

    Journal of medical virology

    2024  Volume 96, Issue 3, Page(s) e29479

    Abstract: Infection with influenza A virus (IAV) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) poses a significant risk to human life, health, and the global economy. Vaccination is one of the most effective strategies in the fight against ... ...

    Abstract Infection with influenza A virus (IAV) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) poses a significant risk to human life, health, and the global economy. Vaccination is one of the most effective strategies in the fight against infectious viruses. In this study, we, for the first time, have evaluated the immunogenicity and protective effect of an influenza/SARS-CoV-2 Omicron subunit combined vaccine adjuvanted with MF59 and administered to BALB/c mice. Results showed that the combined vaccine induced high levels of IgG, IgG
    MeSH term(s) Animals ; Mice ; Humans ; Influenza, Human ; SARS-CoV-2 ; Mice, Inbred BALB C ; Influenza A Virus, H1N1 Subtype ; COVID-19/prevention & control ; Influenza Vaccines ; Vaccines, Combined ; Influenza A virus ; Immunoglobulin G ; Antibodies, Viral ; Antibodies, Neutralizing
    Chemical Substances Influenza Vaccines ; Vaccines, Combined ; Immunoglobulin G ; Antibodies, Viral ; Antibodies, Neutralizing
    Language English
    Publishing date 2024-02-29
    Publishing country United States
    Document type Journal Article
    ZDB-ID 752392-0
    ISSN 1096-9071 ; 0146-6615
    ISSN (online) 1096-9071
    ISSN 0146-6615
    DOI 10.1002/jmv.29479
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Recent Advances in the Development of Virus-Like Particle-Based Flavivirus Vaccines.

    Zhang, Naru / Li, Chaoqun / Jiang, Shibo / Du, Lanying

    Vaccines

    2020  Volume 8, Issue 3

    Abstract: Flaviviruses include several medically important viruses, such as Zika virus (ZIKV), Dengue virus (DENV), West Nile virus (WNV) and Japanese encephalitis virus (JEV). They have expanded in geographic distribution and refocused international attention in ... ...

    Abstract Flaviviruses include several medically important viruses, such as Zika virus (ZIKV), Dengue virus (DENV), West Nile virus (WNV) and Japanese encephalitis virus (JEV). They have expanded in geographic distribution and refocused international attention in recent years. Vaccination is one of the most effective public health strategies for combating flavivirus infections. In this review, we summarized virus-like particle (VLP)-based vaccines against the above four mentioned flaviviruses. Potential strategies to improve the efficacy of VLP-based flavivirus vaccines were also illustrated. The applications of flavivirus VLPs as tools for viral detection and antiviral drug screening were finally proposed.
    Language English
    Publishing date 2020-08-27
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2703319-3
    ISSN 2076-393X
    ISSN 2076-393X
    DOI 10.3390/vaccines8030481
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Recent Advances in the Development of Virus-Like Particle-Based Flavivirus Vaccines

    Naru Zhang / Chaoqun Li / Shibo Jiang / Lanying Du

    Vaccines, Vol 8, Iss 481, p

    2020  Volume 481

    Abstract: Flaviviruses include several medically important viruses, such as Zika virus (ZIKV), Dengue virus (DENV), West Nile virus (WNV) and Japanese encephalitis virus (JEV). They have expanded in geographic distribution and refocused international attention in ... ...

    Abstract Flaviviruses include several medically important viruses, such as Zika virus (ZIKV), Dengue virus (DENV), West Nile virus (WNV) and Japanese encephalitis virus (JEV). They have expanded in geographic distribution and refocused international attention in recent years. Vaccination is one of the most effective public health strategies for combating flavivirus infections. In this review, we summarized virus-like particle (VLP)-based vaccines against the above four mentioned flaviviruses. Potential strategies to improve the efficacy of VLP-based flavivirus vaccines were also illustrated. The applications of flavivirus VLPs as tools for viral detection and antiviral drug screening were finally proposed.
    Keywords flaviviruses ; Zika virus ; Dengue virus ; West Nile virus ; Japanese encephalitis virus ; virus-like particles ; Medicine ; R
    Language English
    Publishing date 2020-08-01T00:00:00Z
    Publisher MDPI AG
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  8. Article ; Online: A Perspective on the Roles of Adjuvants in Developing Highly Potent COVID-19 Vaccines.

    Zhang, Naru / Li, Kangchen / Liu, Zezhong / Nandakumar, Kutty Selva / Jiang, Shibo

    Viruses

    2022  Volume 14, Issue 2

    Abstract: Several countries have made unremitting efforts to develop an optimal vaccine in the fight against coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). With the increasing occurrence of SARS-CoV-2 ... ...

    Abstract Several countries have made unremitting efforts to develop an optimal vaccine in the fight against coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). With the increasing occurrence of SARS-CoV-2 variants, current vaccines show decreased neutralizing activities, especially towards the Omicron variant. In this context, adding appropriate adjuvants to COVID-19 vaccines can substantially reduce the number of required doses and improve efficacy or cross-neutralizing protection. We mainly focus on research progress and achievements associated with adjuvanted COVID-19 subunit and inactivated vaccines. We further compare the advantages and disadvantages of different adjuvant formulations in order to provide a scientific reference for designing an effective strategy for future vaccine development.
    MeSH term(s) Adjuvants, Immunologic/administration & dosage ; Adjuvants, Immunologic/analysis ; Antibodies, Neutralizing/immunology ; Antibodies, Viral/immunology ; COVID-19/prevention & control ; COVID-19 Vaccines/analysis ; COVID-19 Vaccines/immunology ; Humans ; SARS-CoV-2/immunology ; Vaccine Development/methods ; Vaccines, Inactivated
    Chemical Substances Adjuvants, Immunologic ; Antibodies, Neutralizing ; Antibodies, Viral ; COVID-19 Vaccines ; Vaccines, Inactivated
    Language English
    Publishing date 2022-02-14
    Publishing country Switzerland
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2516098-9
    ISSN 1999-4915 ; 1999-4915
    ISSN (online) 1999-4915
    ISSN 1999-4915
    DOI 10.3390/v14020387
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Identification and characterization of a novel 6'-N-aminoglycoside acetyltransferase AAC(6')-Va from a clinical isolate of

    Zhang, Guozhi / Zhang, Lei / Sha, Yuning / Chen, Qiaoying / Lin, Naru / Zhao, Jingxuan / Zhang, Yuan / Ji, Yongan / Jiang, Weiyan / Zhang, Xueya / Li, Qiaoling / Lu, Junwan / Lin, Xi / Li, Kewei / Zhang, Hailin / Bao, Qiyu / Lu, Jun / Hu, Yunliang / Zhu, Tingting

    Frontiers in microbiology

    2023  Volume 14, Page(s) 1229593

    Abstract: Background: Aeromonas: Methods: The function of : Results: The novel aminoglycoside : Conclusion: The novel resistance ... ...

    Abstract Background: Aeromonas
    Methods: The function of
    Results: The novel aminoglycoside
    Conclusion: The novel resistance gene
    Language English
    Publishing date 2023-10-18
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2587354-4
    ISSN 1664-302X
    ISSN 1664-302X
    DOI 10.3389/fmicb.2023.1229593
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: A Perspective on the Roles of Adjuvants in Developing Highly Potent COVID-19 Vaccines

    Zhang, Naru / Li, Kangchen / Liu, Zezhong / Nandakumar, Kutty Selva / Jiang, Shibo

    Viruses. 2022 Feb. 14, v. 14, no. 2

    2022  

    Abstract: Several countries have made unremitting efforts to develop an optimal vaccine in the fight against coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). With the increasing occurrence of SARS-CoV-2 ... ...

    Abstract Several countries have made unremitting efforts to develop an optimal vaccine in the fight against coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). With the increasing occurrence of SARS-CoV-2 variants, current vaccines show decreased neutralizing activities, especially towards the Omicron variant. In this context, adding appropriate adjuvants to COVID-19 vaccines can substantially reduce the number of required doses and improve efficacy or cross-neutralizing protection. We mainly focus on research progress and achievements associated with adjuvanted COVID-19 subunit and inactivated vaccines. We further compare the advantages and disadvantages of different adjuvant formulations in order to provide a scientific reference for designing an effective strategy for future vaccine development.
    Keywords COVID-19 infection ; Severe acute respiratory syndrome coronavirus 2 ; adjuvants ; vaccine development
    Language English
    Dates of publication 2022-0214
    Publishing place Multidisciplinary Digital Publishing Institute
    Document type Article
    ZDB-ID 2516098-9
    ISSN 1999-4915
    ISSN 1999-4915
    DOI 10.3390/v14020387
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

To top